Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Collegium Pharmaceutical, Inc. (COLL) vs Kamada Ltd. (KMDA)

Collegium Pharmaceutical, Inc. and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $737.1M against $509.4M — 1.4× the size. Collegium Pharmaceutical, Inc. trades at the lower P/E: 14.7× against 22.9×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 14.3% against 13.2%. Kamada Ltd. has the higher net margin (11.6% vs 5.93%) and the higher return on invested capital (8.47% vs 7.85%). Across the 21 metrics below, Collegium Pharmaceutical, Inc. leads on 12 and Kamada Ltd. on 9.

Valuation

Metric COLL KMDA Drug Manufacturers Specialty & Generic median
P/E 14.73 22.95 20.14
P/S 0.90 2.63 2.25
P/B 2.34 1.87 1.90
Price to free cash flow n/m 19.18 16.54
EV/EBITDA 4.29 10.33 12.29
EV/Sales 2.07 2.32 2.56
Earnings yield 6.79% 4.36% (2.99%)
Free cash flow yield (5.46%) 5.21% 0.00%

Profitability

Metric COLL KMDA Drug Manufacturers Specialty & Generic median
Gross margin 60.02% 40.82% 53.94%
Operating margin 19.48% 14.51% 0.00%
Net margin 5.93% 11.60% 0.00%
Free cash flow margin 40.62% 13.72% 0.00%
Return on equity 17.61% 8.40% (0.40%)
Return on assets 2.57% 5.92% (3.32%)
Return on invested capital 7.85% 8.47% 0.00%

Growth

Metric COLL KMDA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 14.31% 13.17% 10.01%
EPS growth (last fiscal year) (6.99%) 40.00% —
Revenue growth, 5-year CAGR 20.28% 6.25% 6.74%
Net income growth, 5-year CAGR 18.64% 3.34% 0.00%

Health

Metric COLL KMDA Drug Manufacturers Specialty & Generic median
Debt to equity 3.50 0.02 0.05
Current ratio 1.03 4.06 2.31
Net debt to EBITDA 1.00 (1.59) 0.85

Dividend

Metric COLL KMDA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric COLL KMDA Drug Manufacturers Specialty & Generic median
Market cap 737.06m 509.40m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack